More news: Software
Agency / Source: SAS Institute, Inc.

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

SAS and Thread Launch Proprietary Offering for Biopharma Companies - Joint solution supports biotech industry with modernizing clinical research - THREADresearch.com / SAS.com
SAS and Thread Launch Proprietary Offering for Biopharma Companies

 

PRZOOM - /newswire/ - Cary, NC, United States, 2023/07/19 - Joint solution supports biotech industry with modernizing clinical research - THREADresearch.com / SAS.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Software Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

SAS and Thread today announced the launch of a proprietary offering that enables emerging biopharma companies to modernize their clinical research in a simple and cost-effective way. AI and analytics leader SAS and Thread, a leader in decentralized research, have partnered on a new solution that supports biotech companies with data preparation, evaluation, and submission.

The newly launched offering combines SAS’ comprehensive cloud-native analytics with Thread’s decentralized clinical trial (DCT) and electronic clinical outcome assessment (eCOA) platform to enable biopharma companies to better control and oversee their clinical study data. The regulatory compliance-enabled solution features a consolidated analytics environment that pulls data from multiple sources, including participant- and clinician-reported data provided by Thread. For larger pharmaceutical organizations, Thread’s data also can be surfaced within customer-specific SAS analytical environments.

“To meet the evolving needs of clinical trial participants in the age of digital health, research organizations are transforming the way they discover, develop, manufacture, and commercialize new therapies,” said John Reites, co-founder and CEO of Thread. “We are excited to partner with SAS to provide this unique solution to biopharma customers who want to collect data via next-generation research designs.”

The new partnership starts with the integration of SAS’ Statistical Computing Environment (SCE) solution, built on SAS® Viya®, SAS’ cloud-native, massively parallel AI and analytics platform, with Thread’s technology platform providing data access, analysis, and visualization for shared customers. It will allow the two organizations to build on their initial collaboration into innovative, DCT-specific analytics by combining the unique data elements captured by Thread with SAS AI, machine learning, and visualization.

“With SAS and Thread, biotech companies can modernize clinical research and deliver new therapies to market faster to improve health. And more of their people will benefit from advanced analytics,” said Jason Mann, Vice President of Internet of Things (IoT) at SAS.

About Thread

Thread’s purpose (threadresearch.com) is to leverage its decentralized research platform to enable studies for everyone, everywhere. The company’s uniquely combined clinical research technology and consulting services help biopharma and CROs to design, operate, and scale next-generation research studies and electronic clinical outcome assessment (eCOA) programs for participants, sites, and study teams. Through its comprehensive platform and scientific expertise, Thread empowers studies to be accessible, efficient, and centered on the patient. Backed by health care investors Water Street Healthcare Partners and JLL Partners, Thread is recognized as a leader by Everest Group’s Decentralized Clinical Trial Product PEAK Matrix® Assessment 2021/2022 and positioned in the Leader's Category of the 2022 IDC MarketScape for R&D Decentralized Clinical Trial Technology Solutions Vendor Assessment 2022.

About SAS

SAS (sas.com) is the leader in analytics. Through innovative software and services, SAS empowers and inspires customers around the world to transform data into intelligence. SAS gives you THE POWER TO KNOW®.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Software Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: SAS Institute, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
Software Warnings - IMPORTANT:
Always be aware/cautious about what you download on your computer/mobile! PURCHASE SOFTWARE related keywords / Banner Ads. Click HERE for details!
.

 
  Your Banner Ad showing on ALL
Software articles,
CATCH Visitors via Your Competitors Announcements!


SAS and Thread Launch Proprietary Offering for Biopharma Companies

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Clinical Research | SAS
Contact: Mike Nemecek - SAS.com 
919-531-5140 mike.nemecek[.]sas.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any SAS Institute, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Software via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Press Releases From SAS Institute, Inc. / Company Profile


Read Software Most Recent Related Press Releases:

Yardi Debuts New AI Technology at Apartmentalize
Panasonic Information Systems Selects Oracle Cloud Infrastructure to Drive Modernization of Internal Systems Across the Group
Oracle Payment Cloud Service Now Available in the UK
Siemens Collaborates with Samsung Foundry to Expand 3D-IC Enablement Tools, Optimize Other EDA Solutions for Foundry’s Newest Processes
Safran Expands Asterios, its Development Tool for Critical Embedded Software
Blue Yonder Named Snowflake Retail & Consumer Goods Data Cloud Product Partner of the Year Award Winner
Cornerstone Partners with Udacity, Expanding Access to Expertly Curated Learning Content
Siemens and KU Leuven Collaborate to Research Digital Twin for Smart and Sustainable Products
Manx Telecom Partners with Cornerstone to Grow Skills and Nurture Leaders
SAP Enters into Agreement to Acquire WalkMe, Driving Business Transformation by Enhancing the Customer Experience and Enriching SAP Business AI Offeri

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
.



PREMIUM Members


Visit  Limelon Advertising, Co.

Visit  RightITnow, Inc.

Visit  BizJobs.com







 
  ©2005-2024 PRZOOM - Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today